The prevalence of hepatitis B virus infection in inflammatory bowel disease patients Sep 18, 2008
Reference: Tolentino YFM, Fogaa HS, Zaltman C, Ximenes LLL, Coelho HSM. Hepatitis B virus prevalence and transmission risk factors in inflammatory bowel disease patients at clementino fraga filho university hospital. World J Gastroenterol 2008; 14(20): 3201-3206. (EurekAlert!)
A potential approach to treatment of hepatitis B virus infection Sep 10, 2008
Despite the availability of a safe and efficient vaccine, chronic hepatitis B virus infection remains a major health problem worldwide ... Reference: Zhao F, Hou NB, Song T, He X, Zheng ZR, Ma QJ, Li L, Zhang YH, Zhong H. Cellular DNA repair cofactors affecting hepatitis B virus infection and replication. (EurekAlert!)
Roche wins FDA approval for Hepatitis B test Sep 5, 2008
The test, which uses Roche technology to quantify the amount of Hepatitis B virus DNA in a patient s blood, is the first diagnostic approved for the purpose in the U.S., according to the company. Because the goal of Hepatitis B therapy is to treat until the virus is undetectable in the patient s blood, it is critical for viral load monitoring tests to be able to quantify very low levels of virus. (East Bay Business Times, CA)
Double Hepatitis Vaccine Boosts Immune Response Sep 4, 2008
NEW YORK (Reuters Health) - About 5 percent to 10 percent of adults don't have an adequate immune response when they're vaccinated against the hepatitis B virus, which means they're still at risk of catching the infection. However, a clever strategy may overcome the problem. (MEDLINEplus)
New Approach, Old Drug Show Promise Against Hepatitis C, Research Shows Sep 3, 2008
(July 29, 2008) Using a newly developed method, Utrecht University researchers have mapped the structure and composition of the hepatitis B virus. The researchers were able to map the structure by spraying the. (Science Daily)
Hepatitis B Genotypes And Mutants May Influence Liver Cancer Risk Aug 16, 2008
15, 2008) Infection with hepatitis B virus (HBV) causes liver cancer in some individuals, but not all strains of the virus are associated with the same degree of risk, according to a study published in the August 12 online issue of the Journal of the National Cancer Institute ... Yang et al. Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma ... Hepatitis B virus attacks the. (Science Daily)
Flu vaccine makers ship doses early Aug 15, 2008
The third is a type B virus first seen in Florida in 2006. One of the Brisbane strains showed up in this country after the 2007-08 flu season began, too late to be included in vaccines, according to Michael Shaw of the US Centers for Disease Control and Prevention's influenza division. (Boston Globe)
* Researchers find cancer indicator Aug 14, 2008
Gene specialists at Academia Sinica have spotted a new referential indicator of liver cancer related to the hepatitis B virus, a finding that could prove helpful in the development of new diagnostic procedures, sources at the institution said yesterday. The indicator, discovered by members of Academia Sinicas Genomics Research Center, involved a DNA examination of the genotype of hepatitis B virus ... Meanwhile, if mutations are found in the hepatitis B virus, the risks can increase or... (Taipei Times, Taiwan -- World)
Nano Vaccine For Hepatitis B Shows Promise For Third World Aug 14, 2008
(May 1, 2007) Bananas have emerged as the best candidate to deliver a bite-sized vaccine for hepatitis B virus (HBV) to millions of people in developing countries, according to a recent. (Nov. (Science Daily)
Viread Approved for Hepatitis B Aug 14, 2008
A once-daily tablet, Viread blocks an enzyme called HBV DNA polymerase, which is needed by the hepatitis B virus to replicate in liver cells. HealthDay. (MEDLINEplus)
FDA OKs HIV Drug Viread for Hepatitis B Aug 13, 2008
Hepatitis B is a liver disease caused by the hepatitis B virus ... The hepatitis B virus can spread through blood, semen, or other body fluids ... Viread, taken once a day in a tablet, blocks an enzyme that the hepatitis B virus needs to replicate in liver cells, notes a news release from Viread's maker, California-based Gilead Sciences Inc.. (WebMD)
Gilead HIV drug approved for hepatitis B Aug 13, 2008
The hepatitis B virus causes serious liver disease and also liver cancer ... The hepatitis B virus is up to 100 times more easily transmitted between people than HIV, the virus that causes AIDS. It is believed to cause 80 percent of liver cancer cases. (San Francisco Business Times, CA)
Low Hepatitis B Vaccination Rates Seen in U.S. Newborns Aug 5, 2008
Infants infected with the hepatitis B virus have a 90 percent chance of becoming chronically infected, which can lead to cirrhosis and liver cancer, CDC researchers note. Delivery hospitals play a key role in the national strategy to prevent hepatitis B transmission and should have policies and procedures in place to ensure that hepatitis B vaccination is administered to all newborns before they leave the hospital, they emphasize. (MEDLINEplus)
Structure Of Hepatitis B Mapped By Spraying Virus Jul 30, 2008
ScienceDaily (July 29, 2008) Using a newly developed method, Utrecht University researchers have mapped the structure and composition of the hepatitis B virus ... Using the modified mass spectrometer, the researchers looked at the structure and composition of the hepatitis B virus, a virus that causes severe liver ailments in humans. (Science Daily)
DNA Knot Keeps Viral Genes Tightly Corked Inside Shell, Scientists Discover Jun 24, 2008
(June 23, 2006) Scientists at The Scripps Research Institute have analyzed the structure of hepatitis B virus and found that it has unique features that distinguish it from other enveloped viruses such as influenza. (Feb. (Science Daily)
China casts wider net in crackdowns Jun 13, 2008
The pre-Olympic crackdown has also hit China's independent citizens groups, including those supporting the estimated 100 million Chinese who have the hepatitis B virus. Last month, authorities shut down a popular website that provides help to people with hepatitis B, who often suffer discrimination and social stigma. (Globe and Mail -- International)
New Hope for Liver Diseases May 25, 2008
In another study, Dr. Uchenna Iloeje, director of virology for Global Clinical Research at Bristol-Myers Squibb Co., reported that monitoring the viral load of hepatitis B virus in patients with that disease is a significant predictor of who will be likely to get liver cancer. In the study, researchers followed more than 3,500 patients for 11. (Health-Finder)
Hepatitis B rise leads to migrant screening call May 21, 2008
One in ten of the Chinese immigrant population in Britain is carrying the hepatitis B virus, a survey suggests, leading to calls for all migrants to be screened upon entering the country. Hepatitis B virus (HBV) is the most common serious liver infection in the world, and thought to be the leading cause of liver cancer. (Times Online)
OPEN FORUM: Killers Among Us San Francisco - help us make it hep B free now May 13, 2008
Chronic hepatitis B is a liver disease caused by the hepatitis B virus, a pathogen that is up to 100 times more easily transmitted than HIV. The disease is often called a "silent killer" because it can cause liver cancer, cirrhosis or liver failure without producing symptoms ... Free hepatitis B virus screening. (San Francisco Chronicle -- Opinion)
Seven vaccines you need right now May 9, 2008
Both vaccines protect against the hepatitis B virus, which is spread through sexual contact or contaminated needles and blood. An infection can lead to dangerous liver disease. (CNN -- Health)
Doctors warn of new flu strains in Singapore May 3, 2008
According to the World Health Organisation, these are the Brisbane H3N2 strain and Florida Influenza B virus. Some 630,000 people come down with flu every year, usually in May and June. (Channel NewsAsia, Singapore)
"Gay" Sex Kills Apr 22, 2008
For example, the Hepatitis B virus is about five to six times more prevalent among gays, and Hepatitis C is twice as common ... For example, the Hepatitis B virus is about five to six times more prevalent among gays, and Hepatitis C is twice as common. (Townhall.com)
Flu Bug Bites Hard This Year Apr 19, 2008
We re seeing the presence of an influenza B virus but it was not included in the vaccine formulations used last fall. The vaccines are completely ineffective against this form of virus. (MedHeadlines)
Vaccine leads to big flu season Apr 19, 2008
Marshfield data showed that the vaccine didn't work at all against the Type B virus and was 58 percent effective against the Brisbane virus. Still, with the vaccine being 44 percent, Goedeke said it was wise to get one. (SunOnline)
Flu Season is the Worst in Years Apr 19, 2008
Marshfield data showed that the vaccine was completely ineffective against the Type B virus, and was 58 percent effective against the Brisbane virus. Jernigan acknowledged that some people may lose faith in the flu vaccine and skip it next year. (WTVR.com, VA)
Flu Vaccine Worst In 10 Years Apr 18, 2008
Although the "Brisbane" H3N2 type A flu virus was the most common flu bug this year, Jernigan said, the type B virus is now the predominant strain currently going around. Since the flu vaccine isn't effective against this bug - and isn't totally effective against the Brisbane bug - the CDC is recommending that people who come down with flu-like illnesses ask their doctors about the flu drugs Tamiflu and Relenza. (CBS News)
Flu Viruses Take One-way Ticket Out Of Asia, Then Travel The World Apr 18, 2008
The others are the influenza A (H1N1) subtype and the influenza B virus. Each year, the World Health Organization decides which strains within these three categories to include in the next vaccine, based on the recent activity of strains that are currently circulation. (Science Daily)
Hepatitis B Tied to Bile Duct Cancer Outside Liver Apr 18, 2008
NEW YORK (Reuters Health) - The results of a study published in the International Journal of Cancer suggest there is an association between hepatitis B virus (HBV) infection and an increased risk of extrahepatic bile duct cancer. The extrahepatic bile duct collects bile from the liver, but is located outside of the liver. (MEDLINEplus)
That Flu You Caught? It Came from East and Southeast Asia Apr 17, 2008
According to WHO statistics, 300 million people are vaccinated against the flu each year, receiving an immunization with a cocktail of weakened strains of influenza A (varieties H3N2 and H1N1), along with the influenza B virus to protect against a full infection. Smith says the vaccination provides good protection to the population as a whole, although flu epidemics still cause three million to five million people to become seriously ill and claims 250,000 to 500,000 lives annually. (Scientific American)
Hepatitis B Virus Triggers Cell 'Suicide' In Patients With Chronic Infection Apr 10, 2008
9, 2008) Scientists from UCL (University College London) have identified a key difference between people who can fight the Hepatitis B virus (HBV) off successfully and those who fail to do so -- that a group of cells important in controlling the disease are triggered to 'commit suicide' in patients who are chronically infected ... Hepatitis B virus (HBV) is one of the most common viruses in the world, and ranks as one of the top ten killer infectious diseases ... Journal reference: 'Bim-mediated... (Science Daily)
A Man with Changes in Mental Status after Liver Transplantation Apr 10, 2008
Serologic testing disclosed antibodies to hepatitis C virus (HCV) and hepatitis B virus (HBV) core and surface antigens; tests for hepatitis B surface antigen and antibodies to hepatitis A were negative. The patient began. (New England Journal of Medicine)
Telbivudine versus Lamivudine in Chronic Hepatitis B Apr 3, 2008
20, 2007, issue)1 on the 1-year results of their study comparing telbivudine with lamivudine in patients with hepatitis B virus (HBV) infection. First, the authors elucidate the role of the viral load at week 24 as a predictor for response and resistance. (New England Journal of Medicine)
Pharmasset Receives $10 Million of Working Capital Mar 29, 2008
Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Pharmasset is currently developing three product candidates. (PR Newswire)
BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients Mar 25, 2008
Drug resistance occurs when the hepatitis B virus (HBV) mutates, thereby avoiding the effects of the medication. This can decrease the efficacy of the current medication and may compromise future treatment options. (PR Newswire)
BARACLUDE data show low resistance over 5 years in nucleoside-naive hepatitis B patients Mar 25, 2008
Drug resistance occurs when the hepatitis B virus (HBV) mutates, thereby avoiding the effects of the medication ... BARACLUDE (entecavir) is a prescription medicine used for chronic infection with hepatitis B virus (HBV) in adults where the virus is multiplying and damaging the liver. (EurekAlert!)
China's Hepatitis B carriers face gloomy future Mar 19, 2008
HONG KONG (Reuters) - Madam Yan and 11 other mothers in China turned to the All-China Women's Federation for help after their toddlers were denied places in kindergarten after testing positive for the Hepatitis B virus. "When I see other children going to school happily and mine is alone, my heart drips with blood," Yan wrote. (Scientific American)
Health Department Gives Information on Hepatitis Mar 9, 2008
Hepatitis B is an inflammation of the liver caused by the Hepatitis B virus. It is easily spread by direct contact with the blood of body fluids of an infected person. (Missourian Publishing, MO)
Flu still widespread, but cases might be leveling out Mar 7, 2008
"What's unusual about this season is we have a good proportion of (influenza A viruses) and (an influenza B virus) circulating at the same time. Usually, we'll see A's come through, and then we'll see B's later in the season. Here, we've got three flu viruses hitting us at the same time. I think that makes it seem rather tough.". In Yankton, pediatrician Dawn Larson said flu case numbers seem slightly higher this year. (Sioux City Journal, IO)
3D Virus Image, At Highest Resolution Ever Mar 6, 2008
3D Virus Image Taken At Highest Resolution Ever. 3D Virus Image Taken At Highest Resolution Ever. (Science Daily)
Flu vaccine mismatch causing more cases this year Mar 3, 2008
However, most of the A (H3N2) and B virus strains were different from those contained in the vaccine, suggesting that protection against circulating. This article is for Paid Print Subscribers ONLY.. (Jacksonville Business Journal, FL)
ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products Feb 26, 2008
It is also used in the treatment of acute exposure to hepatitis B following acute exposure to blood containing HBsAg, perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg positive persons, and household exposure of infants to persons with acute hepatitis B virus infection. The groups usually considered at risk are hepatitis B researchers and workers, and many health care professionals. (PR Newswire)
Working Toward Effective Treatment for HBV Infection Feb 25, 2008
25, 2008) Despite the existence of safe and efficient vaccines, hepatitis B virus is one of the most deadly viruses in the world, killing about 1 ... To better understand the direct liver disease induced by hepatitis B virus, recent research brought us one step closer to an effective treatment for HBV infection ... This not only confirmed the previous observation, but showed how the molecular mechanism of how Hepatitis B virus X protein inhibits the liver regeneration. (Science Daily)
Mechanisms of HBV virulence found Feb 25, 2008
WASHINGTON: Scientists at France's National Institute of Health and Medical Research (INSERM) have said that they have uncovered a novel molecular mechanism by which the Hepatitis B virus (HBV) causes liver diseases ... This not only confirmed the previous observation, but showed how the molecular mechanism of how Hepatitis B virus X protein inhibits the liver regeneration, they added. (India Times, India -- Health/Science)
Who found some new mechanisms of HBV virulence? Feb 23, 2008
This not only confirmed the previous observation, but showed how the molecular mechanism of how Hepatitis B virus X protein inhibits the liver regeneration ... Reference: Sidorkiewicz M, Jais JP, Tralhao G, Morosan S, Giannini C, Brezillon N, Soussan P, Delpuech O, Kremsdorf D. Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice. (EurekAlert!)
Flu bug out in full force Feb 22, 2008
But the vaccine s Type B component turned out not to be a good match for the B virus that has been most common this winter. This week, the World Health Organization took the unusual step of recommending that next season s flu vaccine have a completely different makeup from this year s. Wendy Rhinehart, RN BSN with Polk Medical Center said they ve been busy treating local residents suffering from the flu. (Rockmart Journal, GA)
Flu season worsens: Shots fight wrong bugs Feb 17, 2008
But the vaccine's Type B component turned out to be a poor match for the B virus that has been most common this winter. And one of the Type A components turned out to be poorly suited for the Type A H3N2/Brisbane-like strain that now accounts for the largest portion of lab-confirmed cases. (San Francisco Chronicle)
Cough, ache, achoo; is it the flu? Feb 14, 2008
The three vaccine strains - one A (H1N1) virus, one A (H3N2) virus, and one B virus - are representative of the influenza vaccine strains recommended for that year ... However, data also suggests "that protection against the H3N2 and B virus strain in the community might not be optimal.". (The Examiner)
Flu shots defense may belacking Feb 9, 2008
The Type B strain chosen for this years vaccine also was not a good match for most of the B virus strains seen in the United States this flu season, Bresee said. While a less-than-ideal virus match between the viruses in the vaccine and those circulating viruses can reduce vaccine effectiveness, we know from past influenza studies that the vaccine can still protect enough to make illness milder or prevent flu-related complications, Bresee said. (MSNBC -- Health)
Hepatitis B virus infection among pregnant women in Taiwan: comparison between women born in Taiwan and other southeast countries Feb 7, 2008
Other articles by authors. Related articles/pages. (BioMed Central)
Regular Marijuana Use Increases Risk Of Hepatitis C-related Liver Damage Jan 30, 2008
Scientists have investigated 67 spontaneously recovered patients and found that co-infection by hepatitis B virus is. . (Science Daily)
1/28: Tufik.B Virus Infects Local, Mapped Drive Executable Files Jan 29, 2008
B Virus Infects Local, Mapped Drive Executable Files ... B Virus Infects Local, Mapped Drive Executable Files January 28, 2008. (eSecurityPlanet)
1/28: W32.Tufik.B!inf Detects Files Infected by Virus Jan 29, 2008
inf Detects Files Infected by Virus. E-Security Planet Webcasts. (eSecurityPlanet)
China crawls towards judicial reform Jan 25, 2008
Moreover, in some cases, the claims appear to have generated or reinforced public pressure for modest legal reforms, such as the revision of employment regulations that discriminated against carriers of the Hepatitis B virus [7. The government has also enacted limited institutional reforms. (Asia Times Online)
New Test Screens for Flu and Other Viruses Jan 23, 2008
The ProFlu+ test can analyze a single sample for influenza A virus, influenza B virus, and respiratory syncytial virus A and B (RSV). These viruses can cause influenza, pneumonia and an infection of the airways called bronchiolitis. (MEDLINEplus)
Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil Jan 23, 2008
Hepatitis B virus (HBV) isolates have been classified into eight genotypes (A to H) with distinct geographical distributions. HBV genotypes may also influence pathogenic properties and therapeutic features. (BioMed Central)
FDA clears Prodesse respiratory virus test Jan 22, 2008
The product has a platform that allows several tests to be processed using the same sample to detect influenza A virus, influenza B virus, and respiratory syncytial virus A and B (RSV). These viruses can cause influenza, an infection of the airways called bronchiolitis, and pneumonia, and all are among the leading causes of lower respiratory tract infections. (WTN News)
Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic Jan 12, 2008
HORSHAM, PA (January 11, 2008): Nucleonics, Inc., a privately held biotechnology company focused on the development of novel RNA interference (RNAi)-based therapeutics, announced today that the company has begun treating patients in a Phase 1 human safety study of its experimental treatment for chronic Hepatitis B virus (HBV) infection, NUC B1000. NUC B1000 () is an expressed interfering RNA (eiRNA)-based product consisting of a plasmid DNA construct designed to produce four short interfering... (EurekAlert! -- Business News)
Is a universal flu vaccine on its way? Jan 8, 2008
When the M2 protein is linked to a protein from the hepatitis B virus, the hepatitis B proteins cluster together to form particles that display the M2 protein on their surface. This mimics how the M2 protein would be presented during a normal infection, and provokes a stronger immune response than the M2 protein alone when tested in the lab. (Nature News Service)
HK experts find telbivudine works better to suppress HBV Jan 4, 2008
HONG KONG, Jan. 3 (Xinhua) -- Two local universities made their studies results public here Thursday telling that new medication telbivudine suppresses hepatitis B virus (HBV) better than traditional treatments. University of Hong Kong (HKU) and Chinese University of Hong Kong (CUHK) held a joint press conference on Thursday revealing that telbivudine works better than commonly prescribed medicine lamivudine and adefovir in restraining HBV.. (Xinhuanet, China)
Pharmasset Reports Fiscal Year End 2007 Financial Results Jan 1, 2008
The increased operating expenses for fiscal year 2007 were primarily the result of an increase in Phase 3 registration clinical trial expenses for clevudine for the treatment of chronic hepatitis B virus (HBV) infection, as well as drug discovery, non-cash stock compensation and depreciation expenses ... Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). (PR Newswire)
Nonhospital health-care workers at substantial risk of exposure to bloodborne pathogens Dec 21, 2007
Findings from the study also suggest that many of the exposed nurses may be at increased risk of infection with serious bloodborne pathogens, such as the human immunodeficiency virus (HIV), hepatitis C virus and hepatitis B virus, since only 65% of these serious exposures were ever formally reported to the nurses administrator. Fear of getting into trouble, not having enough time to report, and not knowing how to report an exposure, were the three most common reasons given for not reporting. (EurekAlert!)
Standard Hepatitis B Treatment Bested by Newcomer Dec 20, 2007
This occurs in only about 6 percent of people over 5 who are infected with the hepatitis B virus, in about 30 percent of infected children between 1 and 5 years old, and in as many as 90 percent of babies who are infected with the virus ... The goal of treatment is to keep levels of the hepatitis B virus as low as possible ... The number of study volunteers who had undetectable levels of hepatitis B virus by the end of the treatment year were much greater for those on telbivudine. (Health-Finder)
Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B Dec 20, 2007
Background Reducing hepatitis B virus (HBV) replication to minimal levels is emerging as a key therapeutic goal for chronic hepatitis B.. Methods In this double-blind, phase 3 trial, 1370 patients with chronic hepatitis B were randomly assigned to receive 600 mg of telbivudine or 100 mg of lamivudine once daily. (New England Journal of Medicine)
Hepatitis B Vaccine Not Associated With Childhood Multiple Sclerosis Dec 5, 2007
4, 2007) Vaccinating against the hepatitis B virus does not appear to be associated with the risk of developing multiple sclerosis in childhood, according to a new article ... (May 1, 2007) Bananas have emerged as the best candidate to deliver a bite-sized vaccine for hepatitis B virus (HBV) to millions of people in developing countries, according to a recent. (Science Daily)
Hepatitis B Vaccine Is Not Linked To Multiple Sclerosis In Childhood Dec 5, 2007
This controversy created public misgivings about hepatitis B vaccination. Hepatitis B vaccination in children remained low in several countries despite vaccination campaigns supporting early vaccination against hepatitis B in children as a means of inducing strong and long-lasting immunity and despite high levels of hepatitis B-related morbidity and mortality worldwide. (Medical News Today)
